Patent No. EP3986887 (titled "Targeted Protein Degradation Of Parp14 For Use In Therapy") was filed by Abbvie Biotechnology on Jun 18, 2020. The application was issued on Apr 27, 2022.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents